CVS Additional Paid In Capital from 2010 to 2024
| CVS Stock | USD 59.96 0.95 1.61% |
Additional Paid In Capital | First Reported 2009-06-30 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 7.2 B |
Check CVS Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CVS Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 B, Interest Expense of 2.8 B or Selling General Administrative of 40.3 B, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.0243 or PTB Ratio of 1.26. CVS financial statements analysis is a perfect complement when working with CVS Health Valuation or Volatility modules.
CVS | Additional Paid In Capital |
Latest CVS Health's Additional Paid In Capital Growth Pattern
Below is the plot of the Additional Paid In Capital of CVS Health Corp over the last few years. Additional Paid In Capital (or APIC) is an accounting term found on CVS Health Corp Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x CVS Health Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of CVS Health Corp shares and does not have any impact on the value of APIC. It is the excess amount paid by investors over the par value of a company's shares, representing the additional capital contributed by shareholders. CVS Health's Additional Paid In Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CVS Health's overall financial position and show how it may be relating to other accounts over time.
| Additional Paid In Capital | 10 Years Trend |
|
Additional Paid In Capital |
| Timeline |
CVS Additional Paid In Capital Regression Statistics
| Arithmetic Mean | 19,981,216,167 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 85.09 | |
| Mean Deviation | 15,984,972,933 | |
| Median | 32,079,000,000 | |
| Standard Deviation | 17,001,474,355 | |
| Sample Variance | 289050130.2T | |
| Range | 38.7B | |
| R-Value | 0.89 | |
| Mean Square Error | 67472460T | |
| R-Squared | 0.78 | |
| Significance | 0.000012 | |
| Slope | 3,364,499,455 | |
| Total Sum of Squares | 4046701823.4T |
CVS Additional Paid In Capital History
About CVS Health Financial Statements
CVS Health shareholders use historical fundamental indicators, such as Additional Paid In Capital, to determine how well the company is positioned to perform in the future. Although CVS Health investors may analyze each financial statement separately, they are all interrelated. The changes in CVS Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on CVS Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Additional Paid In Capital | 36.9 B | 38.7 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.